Archive: 26/03/2012

Platelet inhibitor reduces size of large heart attacks

The anti-platelet drug abciximab, delivered directly to lesions caused by a heart attack, significantly decreased damage to the heart muscle in high-risk patients while clot aspiration showed no impact, according to research ...

page 7 from 12